• Follow Us
CDI Labs LogoCDI Labs Company Logo
  • LAB SERVICES
      • Service Platforms
      • OVERVIEW
      • HuProt™ Services
      • VirD™ Services
      • VirScan® Services*
      • HuScan® Services*
      • MouseScan™ Services*
      • Tech Access ProgramCustom PhIP-Seq Libraries*
      • Autoantibody Seromics Services
      • OVERVIEW
      • Biomarker Discovery
      • Patient Stratification
      • Patient Response / Adverse Reaction Prediction
      • Diagnostic Development
      • Vaccine Development and Safety
      • Viral Exposure Profiling
      • Target ID Services
      • OVERVIEW
      • Protein-Protein Interactions
      • Protein-Nucleic Acid Interactions
      • Target Deconvolution / Target Discovery
      • Antibody Specificity Validation
      • Post-translational Modification Specificity Testing
      • Chemically Induced Proximity (CIP)
      • Disease Areas
      • OVERVIEW
      • Autoimmune Disease
      • Oncology
      • Neurological Disease
      • Infectious Disease
      • Genetic Disease
      • * Provided exclusively by CDI Labs Canada.
  • SPECIALIZED CRO SERVICES
      • Specialized CRO Services
      • OVERVIEW
      • Antibody Development
      • Antibody Pairs
      • Protein Production
      • Cell Therapy Immunogenicity Testing
      • CRISPR-Cas9 Immunogenicity Testing
      • Post-translational Modification Specificity Profiling
      • Diagnostic Development
  • PROTEOMICS TECHNOLOGIES
      • HuProt™ MicroarrayContains 21,000+ Full-length Human Proteins
      • VirD™ Membrane ProteinContains429 Membrane Proteins and Isoforms
      • VirScan® PhIP-Seq*Detect antibodies against 68,000+ Viral Protein Sequences
      • HuScan® PhIP-Seq*Detect antibodies against 48,921 Human Proteins and Isoforms
      • MouseScan™ PhIP-Seq* Detect antibodies against 50,135 Murine Proteins and Isoforms
      • * Provided exclusively by CDI Labs Canada.
  • BIOINFORMATICS
      • Bioinformatics
      • OVERVIEW
  • RESOURCES
      • Resources
      • Library Content
      • Publications
      • Videos and Webinars
      • FAQs
  • NEWS  &  EVENTS
      • Blogs
      • Events
      • News
  • COMPANY
      • About Us
      • Leadership
      • Meet CDI Labs
      • Tech Access ProgramCustom PhIP-Seq Libraries*
      • Customer Testimonials
      • Contact Us
      • Sign-up for Our eNews
      • Privacy Policy
  • CONTACT US

You are now leaving the CDI Labs U.S. website and will be directed to the CDI Labs Canada website.

< Older Newer >
Download PDF
  • Share

Wednesday, May 25 2017

CDI Labs Expands HuProt™ - The Highest Content Human Proteome Microarray in the World

Proteomics company now producing glass slides printed with recombinant human proteins comprising 81% of the human proteome for high throughput analytics, contract research and hybridoma development services.

MAYAGUEZ, Puerto Rico and BALTIMORE, May 25, 2017 - CDI Laboratories, Inc. has announced that over 1,000 new recombinant proteins will be added to HuProt™ - its human proteome microarray. With 81% of the human proteome available in a powerful and economical analytical platform*, the Company greatly strengthens its position as a global leader in microarray production, content and application development.


HuProt microarrays can generate massive binding profiles in days - not months - and are used in:

  • Serum (biomarker) profiling- disease diagnosis, prognosis; cancer immunotherapy, vaccine development 
  • Protein binding assays- small molecule binding, DNA/RNA binding, enzyme binding specificity, etc.
  • Antibody specificity testing- assess cross-reactivity, identify highest quality research reagents

"We're excited to launch the next generation of HuProt at ASCO 2017 in Chicago on June 3. With each version - and this is v3.1 - we are adding new proteins with the ultimate goal of having the entire human proteome on a slide." said Scott Paschke, CDI VP of Marketing. "Further, the proteins added to the latest generation represent finer coverage of proteins involved in autoimmune-related toxicities and conditions, transcription factor binding, and signal transduction pathways."


In mid-2016, CDI purchased an Arrayjet Ultra Marathon II non-contact piezoelectric (ink jet) robotic printer for its microarray manufacture. This high-capacity state-of-the-art instrument offers significant performance advantages over contact print methods including significant reductions in lot-to-lot variability and inter-assay variability. 


*HuProt microarrays are available for purchase by labs with in-house microarray scanning capability. Alternatively, CDI's Discovery Services division offers contract assay design, research, bioinformatics and custom-configured microarray production on a per-project basis.



About CDI - A privately-owned biotechnology corporation, CDI focuses on protein- and antibody microarray design, production and custom assay services. CDI's flagship - HuProt™ - is the most comprehensive human proteome microarray in the industry, allowing thousands of protein interactions to be done in parallel. HuProt enables R&D of future therapeutic and diagnostic tools to proceed more rapidly and cost-effectively. CDI's Fast-MAb® hybridoma development service addresses the urgent need for monoclonal antibodies with unprecedented specificity for research, diagnostic or therapeutic targets. Fast-MAb antibodies are evaluated for specificity on the HuProt array. The Company exports products world-wide and is expanding its clientele base and its academic and industrial collaborations.


For more information, visit cdi-lab.com.  ASCO booth #22143




Media Contact:

Scott Paschke, Vice President

CDI Laboratories Inc

518-534-2881 (direct)

[email protected]

  • CDI LABSLinkedin Feed
CDI Labs Footer LogoCDI Labs Company Footer Logo

Become part of the CDI Labs community

Sign up to receive emails on our latest news and updates.

Your First Name
Your Last Name
Your Work Email

Please enter ONLY your work email address.

Sign Up Submit Button

PLATFORMS

  • HuProt™ Proteome Microarray
  • VirD™ Membrane Protein Array
  • VirScan® Viral PhIP-Seq*
  • HuScan® Human PhIP-Seq*
  • MouseScan™ Murine PhIP-Seq*
  • * Provided exclusively by CDI Labs Canada.

SERVICES

  • HuProt™ Services
  • VirD™ Services
  • VirScan® Services*
  • HuScan® Services*
  • MouseScan™ Services*
  • Antibody Development
  • Autoantibody Seromics Overview
  • Target ID Overview
  • Disease Areas Overview
  • Specialized CRO Overview
  • Bioinformatics Overview
  • * Provided exclusively by CDI Labs Canada.

COMPANY

  • Resources
  • Library Content
  • Publications
  • FAQs
  • Videos and Webinars
  • Blogs
  • Events
  • News
  • Sign-up for Our eNews
  • About Us
  • Leadership

CONTACT

  • Email: [email protected]
  • Tel: +1 844-539-6296
  • CONTACT US
  • General Inquiries
  • [email protected]
  • Tel: +1 510 858-2855
  • Technical Support
  • [email protected]
  • Tel: +1 844 539-6296
  • Mailing Address
  • PO. Box 569
  • Mayagüez. PR 00681-0569
  • USA
  • CDI Labs - Mayagüez
  • 12 W Mendez Vigo Avenue
  • 2nd Floor
  • Mayagüez, PR 00680
  • USA
  • Tel: +1 939-280-5293
  • DIRECTIONS
  • CDI Labs - Baltimore
  • 1 N. Haven Street
  • Suite B001
  • Baltimore, MD 21224
  • USA
  • Tel: +1 844-539-6296
  • DIRECTIONS
  • CDI Labs Canada - Toronto
  • MaRS Centre - West Tower
  • 661 University Ave
  • Suite 1300
  • Toronto, ON
  • CANADA M5G 0B7
  • Tel: +1 647-243-5289
  • DIRECTIONS
  • Follow Us

FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

© 2025 CDI Labs. All rights reserved.

  • Privacy Policy
  • |
  • Cookie Policy
  • |
  • Terms of Use - Web
  • |
  • Terms & Conditions - Sales
  • |
  • Terms & Conditions - Services